Q&A: Mark Caulfield

Claire Ainsworth

Nature, 2015, vol. 527, issue 7576, S5-S5

Abstract: Mark Caulfield is chief scientist at Genomics England, which was set up in 2013 to deliver the UK 100,000 Genomes Project, initially focusing on cancers, rare diseases and infection. Caulfield, a cardiovascular clinician and researcher, spoke about the UK approach to big data in biomedicine and the role of Genomics England — including how it plans to embed genomic medicine in Britain's National Health Service (NHS).

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/527S5a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:527:y:2015:i:7576:d:10.1038_527s5a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/527S5a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().